ENTA  valuation analysis

Basics
Name: Enanta Pharmaceuticals, Inc
Description: Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $849.79M (1286th)
Sales(TTM): $94.16M (1399th)
Earnings(TTM): -$73.98M (1242nd)

Value
FFER: 1.14*
Actual price: $42.10
* Earnings were reported Aug 05, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Enanta Pharmaceuticals, Inc's earnings decreased from $23.66M to -$73.98M in the last year.
  • Enanta Pharmaceuticals, Inc's operating income decreased from $11.18M to -$84.63M in the last year.
Earnings / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Sales / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Book / MarketCap
Enanta Pharmaceuticals, Inc
"Biotechnology" industry
Equity / Assets
Enanta Pharmaceuticals, Inc
"Biotechnology" industry